September/October 2019

Flu Vaccine is Available

The first shipments of flu vaccine have arrived at the CDC depots. Please notify Susan Kocen if you are ready to begin administering flu vaccine. The updated VISs can be found here: https://www.cdc.gov/vaccines/hcp/vis/current-vis.html?deliveryName=USCDC_11_1-DM6726

Flu Borrowing

For seasonal influenza vaccine, providers may use private-stock seasonal influenza vaccine to vaccinate
VFC-eligible children if VFC seasonal influenza stock is not yet available. Those private stock doses used on VFC-eligible children can later be replaced when VFC stock becomes available. This one directional borrowing exception is unique to seasonal influenza vaccine.

National Immunization Awareness Month

National Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the importance of vaccination for people of all ages. The Public Health Foundation (PHF), in collaboration with the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC), developed toolkits for communicating with parents, patients, and healthcare professionals about immunization. Visit the CDC's new NIAM website today to access these communication resources and find messages that you can use to highlight the benefits of vaccination and improve the health of your community.

CDC Webinar Series on "The Pink Book"

CDC is presenting a 15-part webinar series to provide a chapter-by-chapter overview of the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases. This is a live series of weekly 1-hour webinars that runs through September 26. All sessions begin at 12:00 p.m. (ET). Continuing education will be available for each event. The schedule is located here: https://www2.cdc.gov/vaccines/ed/pinkbook/

Coverage Rate Assessments

The Centers for Disease Control and Prevention (CDC) Immunization Quality Improvement for Providers (IQIP) program is a quality improvement program for VFC-enrolled healthcare providers. The goal of IQIP is to increase vaccination of children and adolescents with all Advisory Committee for Immunization Practices (ACIP)-recommended vaccines by reducing missed opportunities and improving immunization delivery practices at the provider level.


Outstanding VVFC Compliance
Infant, Child, & Adol. Clinic, Alexandria
Practice of Carlos Cruz, Alexandria
Practice of Jacqueline Hoang, Springfield
Practice of Gloti Rodrigues, Alexandria

New VISs

The live attenuated influenza, inactivated influenza, meningococcal ACWY, meningococcal B, MMR, MMRV, varicella, hepatitis B, and Japanese encephalitis vaccine information statements have recently been updated. They are located here: https://www.cdc.gov/vaccines/hcp/vis/current-vis.html?deliveryName=USCDC_11_1-DM6726
Stocks of the previous editions may be used until exhausted.

Adult Vaccine Update

Q: For which adults are 0, 1, or 2 doses of MMR vaccine recommended to prevent measles? Zero doses:
  • Adults born before 1957 except healthcare personnel.
  • Adults born 1957 or later who are at low risk (i.e., not an international traveler, post-high school educational student, or healthcare worker) and who have received one or more documented doses of live measles vaccine.
  • Adults with laboratory evidence of immunity or laboratory confirmation of measles.
One dose of MMR vaccine:
Adults born 1957 or later who are at low risk (i.e., not an international traveler, healthcare worker, or person attending college or other post-high school educational institution) and have no documented vaccination with live measles vaccine and no laboratory evidence of immunity or prior measles infection.
Two doses of MMR vaccine:
High-risk adults without any prior documented live measles vaccination and no laboratory evidence of immunity or prior measles infection, including:
  • Healthcare personnel.
  • International travelers born in 1957 or later.
  • Persons attending colleges and other post-high school educational institutions born in 1957 or later.
Persons who previously received a dose of measles vaccine in 1963–1967 and are unsure which type of vaccine it was, or are sure it was inactivated measles vaccine, should be revaccinated with either one (if low risk) or two (if high risk) doses of MMR vaccine.
Healthcare personnel born before 1957 should be considered for MMR vaccination in the absence of an outbreak, but are recommended for MMR vaccination during outbreaks.